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Objective: To present the short- to midterm outcomes after management of 14 patients with symptomatic isolated
dissection of superior mesenteric artery (SIDSMA) and propose a preliminary treatment algorithm.
Background: SIDSMA is a rare but potentially fatal entity. However, most of these reports were isolated case reports, and
a consensus treatment protocol remains lacking so far. It would be meaningful to propose a reasonable treatment
algorithm for it.
Methods: Patients with SIDSMA who were treated in our center between July 2007 and June 2011 were retrospectively
collected and analyzed. Based upon the abdominal pain and signs, the clinical manifestations have been retrospectively
classiﬁed into grade I (peritonitis absent) and grade II (peritonitis present). Medical treatment mainly included anti-
coagulation, antiplatelet, and bowel rest. Endovascular stent placement and surgical fenestration with exploratory
laparotomy have been selected according to the grade classiﬁcation. Computed tomographic angiography, magnetic
resonance angiography, or duplex scans have been used for diagnosis and follow-up.
Results: Fourteen consecutive patients with SIDSMAwere collected; among them, 13 cases belonged to grade I and one to
grade II. The mean duration from the onset to the admission was 12 ± 12 days (range, 0.5-45 days). The mean distance
from the primary tear to the ostium of superior mesenteric artery (SMA) was 26 ± 4 mm (range, 15-32 mm). Medical
treatment was given for 13 patients of grade I for the ﬁrst 3 to 5 days after admission, and the abdominal pain remarkably
or completely resolved in four patients who received continued medical treatment, whereas the other unresolved nine
patients were converted to endovascular stent placement that succeeded in four and failed in ﬁve patients. Since these ﬁve
cases were free from peritoneal signs, medical treatment was given again instead of an immediate surgical intervention,
and ultimately achieved complete alleviation of abdominal pain within the following 1 week. The mean duration from the
start of medical treatment to the alleviation of symptoms, including the continued medical treatment after the failed
endovascular stent placement, was 8 ± 3 days (range, 4-12 days). The grade II patient underwent a successful emergency
surgical SMA fenestration without bowel resection. Follow-up was accomplished in all 14 cases, ranging from 2 to 48
months (mean, 30 ± 15 months). No intestinal necrosis, morbidity, or mortality developed during hospitalization.
During the follow-up, all patients were free from aneurysmal formation of SMA or chronic intestinal ischemia, and all
stents remained patent.
Conclusions: For grade I SIDSMA,most casesmight be successfully treatedwithmedical therapy, and the endovascular stent
placement appears to be an acceptable alternative ifmedical treatment fails. For grade II SIDSMA, the endovascular stenting
combinedwith laparoscopic exploration and/oropen surgery couldbe a reasonable option. (JVasc Surg2013;57:69S-76S.)Isolated dissection of superior mesenteric artery (SMA)
represents a rare entity, and most of the related literature
was limited to isolated case reports.1-9 Meanwhile, many
of these cases were clinically silent and incidentally identi-
ﬁed by radiologic imaging, and only required the expectant
therapy with imaging surveillance. Hence, symptomatic
isolated dissection of SMA (SIDSMA) is further more
rare, which usually calls for a timely treatment to relievethe Department of Vascular Surgery, Zhongshan Hospital, Fudan
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the potential intestinal infarction. However, a consensus
treatment guideline for it remains unavailable so far
because it is difﬁcult to obtain a large number of cases
with SIDSMA, particularly in a single center.10,11 There-
fore, it has become a question of great concern and interest
whether all SIDSMA cases necessitate an immediate revas-
cularization procedure or medical treatment could be given
as the ﬁrst-line strategy, and what treatment algorithm
would be reasonable for it. The current study is to retro-
spectively analyze the management and short- to midterm
outcomes of 14 patients with SISMAD and to propose
a preliminary treatment algorithm.
METHODS
Data collection and analysis. Cases with SIDSMA
that were treated in our center between July 2007 and
June 2011 were retrospectively collected. The informa-
tion collected included clinical manifestations, treatment
modalities, duration from the onset to the admission, dura-
tion from the start of medical treatment to the alleviation of
symptoms, the rate of intestinal necrosis, perioperative69S
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deﬁned as >50% enlargement compared with the proximal
uninvolved segment, the rate of chronic intestinal ischemia,
and patency rate of the stent.
Grade classiﬁcation. Because abdominal pain was the
most common symptom of SIDSMA, and abdominal signs
were the most important indicators for assessment of intes-
tinal ischemia and infarction, we retrospectively classiﬁed
the clinical manifestations into two grades on the basis of
abdominal pain and signs: grade I (peritonitis absent) and
grade II (peritonitis present).
Treatment selection. For grade I patients, medical
treatment would be given for the ﬁrst 3 to 5 days after
admission. If the abdominal pain was relieved, medical
treatment would be continued. If there was no relief of
the abdominal pain (but without aggravation or signs of
peritoneal irritation), endovascular stent placement would
be performed. If it failed, the surgical conversion would
not be conducted immediately; instead, medical treatment
was given again unless the clinical manifestations developed
up to grade II.
For grade II patients, an emergency surgical interven-
tion, including in situ SMA fenestration and exploratory
laparotomy, would be performed.
Medical treatment. Medical treatment was composed
of (1) antiplatelet (daily oral administration of 75-mg
clopidogrel) during the hospitalization and for 6 months
after discharge; (2) anticoagulation (subcutaneous injection
of low molecular weight heparin) every 12 hours throughout
the hospitalization; (3) daily intravenous administration of
20-mg prostaglandin E1 during the hospitalization; (4) bowel
rest; and (5) antihypertension in cases with hypertension,
including b-blockers, angiotensin-converting enzyme inhibi-
tors, angiotensin receptor blockers, or calcium antagonists
administrated either alone or in combination to maintain the
systolic blood pressure below 140 mm Hg.
Endovascular stent placement. Endovascular stent
placement was performed under local anesthesia and
systemic heparinization through the femoral or brachial
approach. First, the angiogram of the abdominal aorta
was performed to detect any potential coexistent dissection
of the celiac trunk or renal arteries and potential collateral
perfusion into SMA, such as Riolan’s arch from the inferior
mesenteric artery. Second, selective angiogram of SMA was
conducted to reveal the primary entry and extension of the
dissection, perfusion of its main branches, and the distal
ﬂow. Third, a 0.018-inch guidewire (V18; Boston Scien-
tiﬁc, Natick, Mass) was used to cross the primary entry and
get to the distal true lumen, building the passage for the
stent placement. If the true lumen was so compressed by
the false lumen that the guidewire could not get into the
distal true lumen, instead, always into the false lumen,
the endovascular procedure would be abandoned, and
the patient would undergo medical treatment again, during
which the surgical conversion would be carried out only if
the clinical manifestations aggravated up to grade II.
Fourth, the bare stent was placed across the entry site,
typically starting from the oriﬁce of SMA. If the anglebetween SMA and the abdominal aorta was too sharp to be
crossed by the delivery system, the left brachial approach
would be taken. Given the that the stent is typically placed
across the curvature of SMA and passively bent, the self-
expanding stent was preferred. Fifth, the ﬁnal angiogram
was performed to evidence the positioning of the stent and
any improvements on distal perfusion. Finally, the femoral
puncture was closed with Starclose or Proglide (Abbott,
Chicago, Ill), or the brachial cut-down was sutured.
Surgical intervention. Surgical fenestration of SMA
with exploratory laparotomy was performed through the
abdominal midline incision under general anesthesia. An
initial inspection of bowels was conducted to evaluate their
perfusion and viability as the baseline for the comparison
with their subsequent condition after the revascularization.
After elevating the transverse mesocolon, displacing the
small intestine to the right, and completely dividing the
ligament of Treitz, SMA was exposed at the base of
the junction between the small bowel and the transverse
colon mesenteries. Since the in situ fenestration needs
to be performed at the dissection-involved segment, we
managed to identify the affected portion by its following
features: (1) swollen and purple in appearance and (2) weak
or even vanished pulsation. After systemic heparinization,
the target segment would be completely transected, and
the fenestration was achieved by partially resecting the
proximal intimal ﬂap, completely ﬁxing the distal intimal
ﬂap to the adventetia with suturing, and then ﬁnishing the
in situ end-to-end anastomosis. The intestine was exam-
ined again. Viable signs included visible pulsation in the
mesenteric arcade vessels, normal or apparently improved
color, and peristaltic motions. The inviable bowel would be
resected.
Follow-up protocol. Patients were followed up by
duplex or computed tomographic angiography (CTA) at
3 months, 6 months, and yearly thereafter after the primary
treatment, detecting any aneurysmal formation of SMA
and patency of the stent. In addition, any presentations
indicating chronic intestinal ischemia would be recorded,
such as postprandial abdominal pain and weight loss.
RESULTS
Fourteen cases with SISMAD were collected, 12 male
and 2 female, mean age 52 6 7 years (range, 44-63 years);
13 cases belonged to grade I and one (patient 10) to grade
II. The clinical manifestations included abdominal pain,
vomiting, hematochezia, and weight loss. Four patients
had hypertension. Spontaneous dissection occurred in 13
cases, whereas one had the traumatic dissection because
of blunt deceleration. The primary entry site was revealed
around the curvature of SMA in all cases by CTA, magnetic
resonance angiography (MRA), or intraoperative angio-
gram, and the mean distance from the primary entry
tear to the ostium of SMA was 26 6 4 mm (range,
15-32 mm). The mean duration from the onset to the
admission was 12 6 12 days (range, 0.5-45 days). The
mean duration from the start of medical treatment to the
alleviation of symptoms, including the continued medical
Table. Characteristics of 14 patients with SIDSMA
Patient
no.
Age,
years
Coexisting
conditions Grade Symptoms
From onset
to admission,
days Treatment
From medical
treatment to
alleviation, days
Duration of
follow-up,
months
1 46 Hypertension I Abdominal pain 9 M-S (Astron 6*80 mm;
Biotronik, Berlin,
Germany)
NA 12
2 61 NA I Abdominal pain,
hematochezia
20 M-S (Maris 6*40 mm;
Invatec, Brescia, Italy)
NA 42
3 46 Hepatic
hemangioma
I Abdominal pain,
weight loss
25 M-S (Wallstent 6*46 mm;
Boston Scientiﬁc, Natick,
Mass)
NA 48
4 62 Uterine ﬁbroids I Abdominal pain 3 M-S (Maris 6*80 mm,
6*40 mm; Invatec)
NA 28
5 52 NA I Abdominal pain 20 M-S (failed)-M 8 41
6 57 Hypertension I Abdominal pain 10 M-S (failed)-M 12 12
7 57 Hypertension,
hyperlipidemia
I Abdominal pain,
vomiting
45 M-S (failed)-M 10 41
8 46 NA I Abdominal pain 8 M-S (failed)-M 9 32
9 59 NA I Abdominal pain 15 M-S (failed)-M 11 31
10 50 NA 3 Abdominal pain 3 Surgical NA 2
11 44 NA I Abdominal pain 1 Medical 5 45
12 43 NA I Abdominal pain 0.5 Medical 4 43
13 63 Hypertension I Abdominal pain 7 Medical 4 34
14 44 Trauma I Abdominal pain 6 Medical 5 12
M-S, Medical treatment, then endovascular stent placement; M-S (failed)-M, Medical treatment, then endovascular stent placement but failed, then medical
treatment again; NA, not available; SIDSMA, symptomatic isolated dissection of superior mesenteric artery.
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patients 5 to 9, was 8 6 3 days (range, 4-12 days). Their
clinical characteristics are shown in the Table.
During the ﬁrst 3- to 5-day medical treatment, the
abdominal pain was remarkably or completely relieved in
patients 11 to 14 and did not subside in patients 1 to 9
(but without aggravation or signs of peritoneal irritation).
The endovascular stent placement was then performed in
patients 1 to 9, which technically succeeded in four (patients
1-4, 44%) and failed in ﬁve patients (patients 5-9, 56%). A
single stent was placed across the primary entry site in
patients 1 to 3. In patient 4, the delivery system could not
be introduced into SMA via the femoral approach; there-
fore, the brachial approach was taken; the proximal stent
(Maris 6*80 mm; Invatec, Brescia, Italy) had foreshortened
during deployment, causing inadequate proximal landing
with only 1 cm proximal to the entry and endoleak, hence,
an additional stent (Maris 6*80 mm; Invatec) was deployed
more proximally with overlapping of the ﬁrst one, achieving
an adequate proximal anchoring and disappearance of endo-
leak. Riolan’s arch existed before stenting and disappeared
afterwards (Fig 1). The ﬁnal angiogram demonstrated
marked improvements on distal perfusion in all four patients
whose clinical presentations were relieved immediately after
stenting. All stents were evidenced patent by duplex scan or
CTA during the follow-up (mean, 33 6 16 months; range,
12-48 months). In patients 5 to 9, stent placement was
abandoned because the guidewire could not cannulate
into the true lumen, tightly compressed by the false one;
instead, the guidewire always entered the false lumen rather
than cannulating into the true lumen. Given they were free
from peritoneal signs, medical treatment was given againinstead of an immediate surgical intervention, and symp-
toms were gradually alleviated within the following week.
Patient 10 had progressive abdominal pain for 3 days
with signs of peritoneal irritation at admission, and CTA
showed that the true lumen was signiﬁcantly compressed
by the enlarged false lumen. Given the suspected intestinal
necrosis requiring the exploratory laparotomy, surgical in
situ fenestration of SMA was selected. Exploration found
(1) weak peristalsis and pallor of the ileum; (2) weak pulsa-
tions of the distal SMA; (3) swelling and purple color of
the middle segment of SMA; and (4) no foul-smelling-
seroperitoneum or bowel necrosis. After fenestration,
exploration was repeated and found that the bowel and
pulsations of the distal SMA were much improved after
revascularization, and no nonviable bowels were detected.
The abdominal pain and signs of peritoneal irritation van-
ished on the ﬁrst postoperative day. CTA at 1 month
revealed disappearance of the distal false lumen, opaciﬁca-
tion of much more SMA branches, and signiﬁcantly
improved distal perfusion (Fig 2).
Hence, we ﬁnally got three groups: medical (patients
5-9 and patients 11-14), endovascular (patients 1-4), and
surgical group (patient 10). Interestingly, in all 14 cases,
no intestinal necrosis, morbidity, or mortality developed
during hospitalization. During the follow-up, all patients
were free from aneurysmal formation of SMA or chronic
intestinal ischemia, and all stents remained patent. In nine
patients eventually treated without intervention (four with
early resolution of symptoms and ﬁve following failed inter-
vention), the dissection persisted with the false lumen
almost unchanged in eight cases (six had a patent and two
had a thrombosed false lumen at the onset) and completely
Fig 1. In patient 4, (A) Riolan’s arch (three long arrows) was perfused from the inferior mesenteric artery (IMA, short
arrow). B, The primary entry site (arrow) was located 30 mm distal to the origin of superior mesenteric artery (SMA)
with the true lumen highly compressed by the false one and impaired perfusion of distal SMA and its main branches. C,
A stent (Maris 6  80 mm; Invatec, Brescia, Italy) was placed via the brachial artery after failure in the attempted
femoral approach. However, the stent had foreshortened during deployment, causing inadequate proximal landing and
endoleak (short arrow). Meanwhile, it was noted that the Riolan’s arch disappeared with only IMA (long arrow)
opaciﬁed. D, An additional stent (Maris 6  40 mm) was then deployed more proximally with its proximal end (short
arrow) a little bit protruding into the abdominal aorta, and endoleak vanished. The IMA (long arrow) could still be
visualized, whereas Riolan’s arch could not. E and F, The follow-up computed tomographic angiography (CTA) at 16
months revealed patent stent and satisfactory perfusion of SMA and its main branches.
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onset.
DISCUSSION
Isolated dissection of SMA was rare and ﬁrst reported
by Bauersfeld in 1947.12 A study based on 6666 autopsies
showed that the postmortem incidence of isolated sponta-
neous SMA dissection was 0.06%.13 The potential etiologic
factors included arteriosclerosis, medial degeneration of
the arterial wall, trauma, inﬂammation, and so on.14-16
Compared with aortic dissection, isolated SMA dissection
was less frequently associated with hypertension that coex-
isted in four out of 14 cases in the current study,
accounting for 29%. Kim et al17 compared the demo-
graphics and characteristics of 47 SMA dissections and 43
aortic dissections, and the results demonstrated that hyper-
tension coexisted in 66% of aortic dissections, whereas it
existed in 30% of SMA dissections. The primary entry site
of SMA dissection in our series was located at the greater
curve of the curvature of SMA, and the mean distancefrom it to the origin of SMA was 26 6 4 mm, similar to
the results from Solis’ investigation on the location of the
primary entry tear of SMA dissection, which found that it
was typically at 15 to 30 mm distal to the origin of
SMA.14 Two explanations might underlie this phenom-
enon. First, this segment of SMA is the transition area
from its ﬁxed portion under the pancreas to its mobile
segment at the mesenteric root, and the abnormal shearing
stress might result. Second, this location is right around the
curvature of SMA, which might mechanically provoke the
occurrence of the entry tear. Park et al18 performed the
ﬂuid dynamic study in patients with SMA dissection and
found abnormal mechanical stresses at the anterior wall
around the convex portion of SMA.
In terms of treatment of isolated SMA dissections, it is
not difﬁcult to decide on either an expectant treatment for
asymptomatic patients or an emergency operation for
SIDSMA with peritonitis (grade II). Nevertheless, it
remains undetermined so far whether an immediate inter-
vention was imperative for SIDSMA without peritonitis
Fig. 2. In patient 10, the preoperative computed tomographic angiography (CTA) showed (A) the true lumen (short
arrow) slightly compressed by the thrombosed false lumen (long arrow) at the proximal portion of superior mesenteric
artery (SMA) and (B) the true lumen (short arrow) highly compressed by the patent false lumen (long arrow) at the
middle segment of SMA. C, The middle portion (arrow) of SMA appeared big in diameter, however, the majority of
the opaciﬁed area was the false lumen rather than the true one, underlying a few branches opaciﬁed and the distal
perfusion signiﬁcantly impaired. Intraoperatively, (D) the exploration found the pallor of the distal ileum (left side of the
arrow) and (H) after the middle segment of SMA was transected, two lumens were disclosed, the small true lumen
(short arrow) and the big false lumen (long arrow). The follow-up CTA at 1 month demonstrated (E) at the proximal
portion of SMA, the true (short arrow) and false lumens (long arrow) remained unchanged. F, At the middle segment
immediately distal to the surgical fenestration, the false lumen was eliminated, and the true lumen (arrow) was
dramatically expanded.G, The proximal segment of SMA was expanded compared with the preoperative CTA (C), the
middle portion (arrow) appeared unchanged in diameter; nevertheless, it was the true lumen that was opaciﬁed, rather
than the false lumen, underlying much more branches visualized and the distal perfusion markedly improved.
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vascular or surgical intervention in prevention of the
possible intestinal infarction,4 whereas others addressed
that it was a self-limiting course, and conservative manage-
ment could achieve satisfactory results.1-4,19,20 Ideally, the
selection of the treatment modality could be based on
a randomized control trial comparing the revascularization
intervention with medical treatment in this subgroup,
which, however, remained unavailable so far. Currently, it
depends more on the physician’s individual preference.
To ﬁnd a reasonable treatment algorithm for SIDSMA,
we tried medical treatment in 13 grade I patients for the
ﬁrst 3 to 5 days. The outcomes showed that abdominal
pain resolved in four cases and was unresolved in nine cases
that were subsequently converted to the endovascular
treatment. The stent placement succeeded in four cases
and failed in ﬁve cases that were then given medical treat-
ment again instead of an immediate surgical conversion,
given the absence of peritonitis. Interestingly, medical
management also generated good durable outcomes in
these ﬁve cases after technically failed stenting, implicating
that the attempted endovascular intervention could have
been spared. On the other hand, among those grade Ipatients whose clinical manifestations failed to be relieved
or even aggravated following the initial medical treatment,
it would be rather difﬁcult to predict in which individual
cases ischemia might progress to grade II and at what
time during the prolonged observation. After weighing
the potential catastrophic consequence from the intestinal
necrosis against the mini-invasion of endovascular inter-
vention, it would be acceptable to try an intraluminal
stenting in this setting. Even if it technically fails, the inva-
sion of such a procedure would be just like a diagnostic
angiography.
Given the small number of patients in each group,
comparative analyses among the three groups have not
been performed because any statistically signiﬁcant results
would be inconclusive and meaningless. However, it
seemed to be apparent that the mortality and morbidity,
the rate of symptom alleviation, and freedom from aneu-
rysmal formation or chronic ischemia were nearly equivalent
between the endovascular and medical groups, indicating
that medical treatment could yield acceptable effects for
grade I SIDSMA.
Gobble and his associates recently reported nine cases
with isolated SMA dissection, including three incidental
Fig. 3. Treatment algorithm for symptomatic isolated dissection of superior mesenteric artery (SIDSMA).
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them, three symptomatic cases were successfully treated by
endovascular stent placement with all stents patent during
the follow-up, whereas another three were managed by anti-
coagulation management. Furthermore, an extensive review
had been made by the authors, revealing 106 documented
cases with an isolated SMA dissection, among which 31
out of 56 (55%) had been successfully treated with the
conservative therapy. Moreover, as many as 21 patients
were symptomatic among those 31 patients. More recently,
Cho et al19 presented encouraging outcomes of anticoagu-
lation and/or antiplatelet therapy for seven SIDSMA cases,
in which clinical symptoms disappeared within 14 days,
which was similar to ours (mean, 8 6 3 days), and noSMA dissection-related mortality or morbidity had been
observed during a mean follow-up of 23 months. Yun
et al22 reported 32 patients with spontaneous isolated
dissection of SMA, among whom 28 patients (18 symptom-
atic and 10 asymptomatic) were successfully treated con-
servatively except for only one patient needing bowel
resection. All these ﬁndings from the literature appeared
consistent with the interpretation from our series that
medical treatment might be a feasible primary strategy for
grade I SIDSMA.
As for medical treatment for SIDSMA, there is no con-
sensus on the optimal protocol to date. Some investigators
advocate anticoagulation and/or antiplatelet as the ﬁrst-
line strategy2,5,19 so as to prevent thrombosis in the true
JOURNAL OF VASCULAR SURGERY
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ence in treatment of spontaneous dissection of the internal
carotid artery that represented the most common periph-
eral artery developing spontaneous dissection followed
by SMA.4,23 However, there is currently no agreement
on the duration of anticoagulation and/or antiplatelet
therapy. Cho et al19 suggested that it should be continued
until the dissection has disappeared. Some authors consid-
ered both anticoagulation and antiplatelet therapy unnec-
essary for SIDSMA.20,22,24 Yun et al treated 28 cases
with SMA dissection in a conservative manner, among
which only ﬁve were given anticoagulation and 23 had
neither anticoagulation nor antiplatelet, and there was no
signiﬁcant difference between the two groups in terms of
treatment outcomes. 22 On the other hand, all these
surveys at least had not observed increased risk of bleeding
after anticoagulation and/or antiplatelet therapy. There-
fore, we used both treatments during hospitalization and
only antiplatelet after discharge, and the overall results
appeared fairly acceptable.
As its application in most other vascular diseases, endo-
vascular stent placement in the management of SIDSMA
was characterized by mini-invasion, safety, and efﬁ-
cacy.6,8,25,26 The four stented cases in our series were all
free from any procedure-related complications, and all
stents were evidenced patent by CTA or duplex scan
during follow-up ranging from 12 to 48 months. It was
noted that there were ﬁve technical failures of endovascular
stent placement in this series, and that all of them were
attributable to guidewire failure to cannulate into the
true lumen. The entry tear of SMA dissection usually
occurs at the greater curve around the curvature of SMA
with the false and true lumen frequently going along the
greater and lesser curve, respectively, similar to the Stan-
ford type B aortic dissection. With the femoral approach,
the guidewire goes through the SMA typically along the
greater curve and, thus, tends to cannulate into the false
rather than the true lumen, especially when it is highly
compressed by the false lumen. In this setting, the brachial
approach might be a helpful alternative by which it would
be easier to adjust the guidewire toward different direc-
tions, even though, to our knowledge, there was no study
comparing the technical success rate in SMA intervention
between the femoral and brachial approaches, whereas
both of them have been reported to be feasible.4,6,21,27
The suggested indications for surgical repair of
SIDSMA contained persistent abdominal pain despite anti-
coagulation, thrombosis in the true lumen, narrowing of
the true lumen because of compression, progressive aneu-
rysmal enlargement, rupture, and suspected intestinal
necrosis requiring exploratory laparotomy.9,28,29 The
procedure types included aortomesenteric or iliomesenteric
bypass, SMA transposition to the aorta, endoaneurysmor-
rhaphy, thrombectomy, and intimectomy with or without
patchplasty.7,9,30-32 In patient 10, given the peritonitis
and probable bowel resection, exploratory laparotomy
and surgical fenestration were performed. Compared with
intimectomy, although fenestration failed to fully openthe proximal true lumen, which was compressed by the
thrombosed proximal false lumen, this technique was easier
and only needed exposure and dissection of a relatively
shorter segment of SMA, especially in the presence of
inﬂammatory reaction around it. Meanwhile, the distal
perfusion in the true lumen could be hemodynamically
improved by eliminating the distal patent false lumen, which
had signiﬁcantly compressed the true lumen (Fig 2). On the
other hand, there were some limitations and contraindica-
tions for the fenestration procedure, such as in the setting
of aneurysmal formation, long dissection, and remarkable
organized thrombi. It was also worth noting in patient 10
that peritonitis did not necessarily mean intestinal necrosis
and need for bowel resection. Therefore, for grade II
SIDSMA, it might be reasonable to try endovascular stent-
ing and laparoscopic exploration ﬁrst to spare the unneces-
sary laparotomy, which could be used as a last resort, in the
setting of endovascular technical failure or positive laparo-
scopic ﬁndings. In addition, there were some common
anatomic ﬁndings on angiography and/or CTA among
ﬁve cases undergoing endovascular or surgical intervention.
They are: (1) no re-entry has been identiﬁed; (2) the false
lumen was patent or partially/completely thrombosed and
much bigger in diameter than the true lumen; and (3) the
true lumen was apparently compressed by the false lumen.
(Figs 1, B and 2)
In summary, themajority of grade I SIDSMAcases could
be successfully treated with medical therapy. The endo-
vascular stent placement could safely and effectively restore
the SMA perfusion with a satisfactory patency rate in medi-
cally unsuccessful cases, and the brachial approach might
promote its technical success rate. For grade II SIDSMA,
the endovascular stenting combined with laparoscopic
exploration and/or open surgery could be a reasonable
option. Based upon the experience above, a preliminary
treatment algorithm for SIDSMA is proposed (Fig 3).
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